THEPAPEUTIC STRATEGY OF ULCERATIVE COLITIS TARGETING UROKINASE-TYPE PLASMINOGEN ACTIVATOR

被引:0
|
作者
Kida, Yoshifumi
Okahisa, Toshiya
Sato, Yasushi
Bando, Masahiro
Fujimoto, Shota
Nakagawa, Tadahiko
Kawaguchi, Tomoyuki
Nakamura, Fumika
Okamoto, Koichi
Miyamoto, Hiroshi
Sogabe, Masahiro
Tsuneyama, Koichi
Takayama, Tetsuji
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
741
引用
收藏
页码:S151 / S151
页数:1
相关论文
共 50 条
  • [1] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [2] Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
    Yoshifumi Kida
    Toshiya Okahisa
    Yasushi Sato
    Masahiro Bando
    Shota Fujimoto
    Beibei Ma
    Tadahiko Nakagawa
    Tomoyuki Kawaguchi
    Fumika Nakamura
    Koichi Okamoto
    Hiroshi Miyamoto
    Masahiro Sogabe
    Koichi Tsuneyama
    Tetsuji Takayama
    Scientific Reports, 13
  • [3] Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
    Kida, Yoshifumi
    Okahisa, Toshiya
    Sato, Yasushi
    Bando, Masahiro
    Fujimoto, Shota
    Ma, Beibei
    Nakagawa, Tadahiko
    Kawaguchi, Tomoyuki
    Nakamura, Fumika
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Sogabe, Masahiro
    Tsuneyama, Koichi
    Takayama, Tetsuji
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [5] Targeting urokinase-type plasminogen activator and its receptor for cancer therapy
    Nozaki, Shinichi
    Endo, Yoshio
    Nakahara, Hirokazu
    Yoshizawa, Kunio
    Ohara, Teruhisa
    Yamamoto, Etsuhide
    ANTI-CANCER DRUGS, 2006, 17 (10) : 1109 - 1117
  • [6] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [7] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [8] Nuclear translocation of urokinase-type plasminogen activator
    Stepanova, V.
    Kuo, A.
    Higazi, A.
    Yarovoi, S.
    Bdeir, K.
    Cines, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 228 - 228
  • [9] Plasma clearance of urokinase-type plasminogen activator
    van der Kaaden, ME
    Rijken, DC
    van Berkel, TJC
    Kuiper, J
    FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04): : 251 - 258
  • [10] Urokinase-type plasminogen activator, an endogenous antibiotic
    Jin, T
    Bokarewa, M
    Tarkowski, A
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03): : 429 - 437